Literature DB >> 15788369

Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers.

S Yamaori1, H Yamazaki, S Iwano, K Kiyotani, K Matsumura, T Saito, A Parkinson, K Nakagawa, T Kamataki.   

Abstract

Using a newly developed real-time reverse transcriptase-polymerase chain reaction method, mRNAs were quantitated for CYP3A4, CYP3A5 and CYP3A7 in adult livers from 24 Japanese and 24 Caucasian subjects to elucidate the potential ethnic differences in the expression levels of human cytochrome P450 (CYP) 3As. The expression level of CYP3A4 mRNA in Japanese livers (n = 24) was approximately three times higher than that in Caucasian livers (n = 24, p < 0.001). The mean level of CYP3A5 mRNA was approximately twice higher in Japanese (n = 9) than in Caucasians (n = 5) heterozygous for the CYP3A5 *1 allele (p = 0.057). The CYP3A7 mRNA level was twice higher in Japanese (n = 24) than in Caucasians (n = 22) carrying the CYP3A7 *1A/ *1A genotype (p = 0.042). The level of CYP3A4 mRNA did not correlate with those of CYP3A5 (r = 0.044, n = 24) or CYP3A7 (r = 0.21, n = 24) mRNAs in Japanese livers in contrast to co-regulatory expression of CYP3A4, CYP3A5 and CYP3A7 in Caucasian livers. The results indicate that there are ethnic differences in the expression levels of adult liver CYP3A mRNAs between Japanese and Caucasians, and that the mechanism(s) regulating the hepatic CYP3A expression may be different between these ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788369     DOI: 10.1080/00498250400021796

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  16 in total

1.  Reply to letter to the editor: "The dosage of rifabutin in H. pylori eradication regimen should be appropriately determined in each area of the world".

Authors:  Hideki Mori; Hidekazu Suzuki
Journal:  United European Gastroenterol J       Date:  2016-05-27       Impact factor: 4.623

2.  Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children.

Authors:  Elizabeth J Thompson; Huali Wu; Anil Maharaj; Andrea N Edginton; Stephen J Balevic; Marjan Cobbaert; Anthony P Cunningham; Christoph P Hornik; Michael Cohen-Wolkowiez
Journal:  Clin Pharmacokinet       Date:  2019-07       Impact factor: 6.447

3.  Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries.

Authors:  Madelé van Dyk; Jean-Claude Marshall; Michael J Sorich; Linda S Wood; Andrew Rowland
Journal:  Eur J Clin Pharmacol       Date:  2018-03-23       Impact factor: 2.953

4.  Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.

Authors:  Hiroshi Yamazaki; Minako Nakamoto; Makiko Shimizu; Norie Murayama; Toshiro Niwa
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

5.  Single nucleotide polymorphism of CYP3A4 intron 2 and its influence on CYP3A4 mRNA expression and liver enzymatic activity in human liver.

Authors:  Min Huang; Han-Ming Wang; Yu Guo; Jie Ping; Man Chen; Dan Xu; Hui Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31

6.  Drug interactions of thalidomide with midazolam and cyclosporine A: heterotropic cooperativity of human cytochrome P450 3A5.

Authors:  Yusuke Okada; Norie Murayama; Chihiro Yanagida; Makiko Shimizu; F Peter Guengerich; Hiroshi Yamazaki
Journal:  Drug Metab Dispos       Date:  2008-10-23       Impact factor: 3.922

7.  Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure.

Authors:  Andrew Rowland; Warit Ruanglertboon; Madelé van Dyk; Dhilushi Wijayakumara; Linda S Wood; Robyn Meech; Peter I Mackenzie; A David Rodrigues; Jean-Claude Marshall; Michael J Sorich
Journal:  Br J Clin Pharmacol       Date:  2018-11-16       Impact factor: 4.335

8.  CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with reduced CYP3A4 protein level and function in human liver microsomes.

Authors:  Maho Okubo; Norie Murayama; Makiko Shimizu; Tsutomu Shimada; F Peter Guengerich; Hiroshi Yamazaki
Journal:  J Toxicol Sci       Date:  2013       Impact factor: 2.196

9.  Identification of Ginkgo biloba as a novel activator of pregnane X receptor.

Authors:  Eugene Y H Yeung; Tatsuya Sueyoshi; Masahiko Negishi; Thomas K H Chang
Journal:  Drug Metab Dispos       Date:  2008-08-25       Impact factor: 3.922

10.  Metabolism of polybrominated diphenyl ethers (PBDEs) by human hepatocytes in vitro.

Authors:  Heather M Stapleton; Shannon M Kelly; Ruoting Pei; Robert J Letcher; Claudia Gunsch
Journal:  Environ Health Perspect       Date:  2008-09-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.